AstraZeneca PLC (AZN)
203.61
+3.14
(+1.57%)
USD |
NYSE |
Apr 17, 10:04
AstraZeneca Research and Development Expense (Quarterly) : 3.725B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GSK Plc | 3.112B |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Mereo BioPharma Group Plc | 4.187M |
| Moderna, Inc. | 708.00M |
| Abivax SA | 51.68M |